fashion -WSS

fashion

author：hotspot 2025-09-28 12:10:18 - browse：91

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： STAT Readout Newsletter: Biotech news today

hotspot

focus

WSS

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Childhood cancer progress stalls for Black, Hispanic kids: Report

How AI can help patients find reliable information about doctors

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

NYU radiologists take on the challenge of expensive MRI machines

explore

fashion

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Apple is now the first public company to be valued at $3 trillion

In key trial, Verve's treatment lowers cholesterol levels in patients

What does generative AI mean for health care? We asked experts

Weight loss drug costs may need more research, senator suggests

How one medical school became remarkably diverse

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Alkermes shareholders re

Poor hospice wound care hurts patients and families

leisure time

In key trial, Verve's treatment lowers cholesterol levels in patients

UnitedHealth, Optum discontinue NaviHealth name

STAT Summit: Meghan O’Rourke on making chronic illness visible

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Merck, Daiichi strike cancer drug pact worth up to $22 billion

STAT Summit: The economic case for universal basic health care

hotspot

focus

focus

Wikipedia